Cargando…
SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
SHP2 is a ubiquitous tyrosine phosphatase involved in regulating both tumor and immune cell signaling. In this study, we discovered a novel immune modulatory function of SHP2. Targeting this protein with allosteric SHP2 inhibitors promoted anti-tumor immunity, including enhancing T cell cytotoxic fu...
Ejemplares similares
-
Colon stroma mediates an inflammation-driven fibroblastic response controlling matrix remodeling and healing
por: Jasso, Guadalupe J., et al.
Publicado: (2022) -
TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts
por: Grauel, Angelo L., et al.
Publicado: (2020) -
Characterization of sabatolimab, a novel immunotherapy with immuno-myeloid activity directed against TIM-3 receptor
por: Schwartz, Stephanie, et al.
Publicado: (2022) -
Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR
por: Lu, Hengyu, et al.
Publicado: (2020) -
Accounting for tumor heterogeneity when using CRISPR-Cas9 for cancer progression and drug sensitivity studies
por: Olive, Jessica F., et al.
Publicado: (2018)